PHASE 2 STUDY
Clinical trials for PHASE 2 STUDY explained in plain language.
Never miss a new study
Get alerted when new PHASE 2 STUDY trials appear
Sign up with your email to follow new studies for PHASE 2 STUDY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo targets Hard-to-Treat pancreatic cancer
Disease control Recruiting nowThis study tests whether adding the drug BMS-986504 to standard chemotherapy can help control pancreatic cancer in people whose tumors have a specific genetic change (MTAP deletion). About 60 adults with this cancer type will receive the combination either before and after surger…
Matched conditions: PHASE 2 STUDY
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 07:14 UTC
-
New hope for High-Risk MCL: targeted therapy combo shows promise
Disease control Recruiting nowThis study tests whether giving the drug glofitamab after an initial treatment with BTKi and rituximab can better control high-risk mantle cell lymphoma (MCL) in people who have not been treated before. About 30 adults with newly diagnosed, high-risk MCL will receive this two-ste…
Matched conditions: PHASE 2 STUDY
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 07:08 UTC